A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers

NCT04372719 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Influenza, Human

Interventions

DRUG: H3N2

Sponsor

SGS Life Sciences, a division of SGS Belgium NV